ZYUS Life Sciences Corp. Closes the Market
July 19 2023 - 4:50PM
PR Newswire (Canada)
TORONTO, July 19,
2023 /CNW/ - Brent Zettl, President and Chief
Executive Officer, ZYUS Life Sciences Corp. ("ZYUS" or the
"Company") (TSXV: ZYUS), and his team joined Robert Peterman, Vice President, Global Business
Development, Toronto Stock Exchange (TSX), to close the market and
celebrate the Company's listing on TSX Venture Exchange.
ZYUS is a Canadian life sciences company committed to
reinventing the treatment of chronic and neuropathic pain by
harnessing the therapeutic properties of cannabinoid
formulations.
Through scientific discovery and clinical research, they are
focused on shifting the paradigm in pain management with the
development of pharmaceutical drug product candidates and
intellectual property activities to protect our novel
cannabinoid-based therapies.
SOURCE Toronto Stock Exchange
Copyright 2023 Canada NewsWire
Zyus Life Sciences (TSXV:ZYUS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Zyus Life Sciences (TSXV:ZYUS)
Historical Stock Chart
From Dec 2023 to Dec 2024